Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "M05" (71)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Alendronic Acid (M05BA04) 12 products
WHO-DDD
IP
CI
Fosamax 70 mg
-
T
4 Tablet(s)
17.76
35.65
10 %
Tablets: Acidum Alendronicum 70 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Fosamax 70 mg
-
T
12 Tablet(s)
51.11
71.80
10 %
Tablets: Acidum Alendronicum 70 mg
Organon GmbH
B / SL / SO
FB
G
IP
CI
Alendronat Sandoz 70
4
16.19
34.05
10 %
Coated tablets: Acidum Alendronicum 70 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Alendronat Sandoz 70
12
46.60
67.20
10 %
Coated tablets: Acidum Alendronicum 70 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Alendronat Spirig HC 70 mg
4 Tablet(s)
16.19
34.05
10 %
Tablets: Acidum Alendronicum 70 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Alendronat Spirig HC 70 mg
12 Tablet(s)
46.60
67.20
10 %
Tablets: Acidum Alendronicum 70 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Alendronat Zentiva
4
15.00
32.85
10 %
Weekly tablets: Acidum Alendronicum 70 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Alendronat Zentiva
12
43.39
63.90
10 %
Weekly tablets: Acidum Alendronicum 70 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Alendron-Mepha 70 mg
4 Tablet(s)
16.17
34.05
10 %
Filmtablette: Acidum Alendronicum 70 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Alendron-Mepha 70 mg
12 Tablet(s)
46.60
67.20
10 %
Filmtablette: Acidum Alendronicum 70 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Binosto 70 mg
4 Tablet(s)
17.42
35.30
10 %
Comprimés effervescents: Acidum Alendronicum 70 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Binosto 70 mg
12
44.43
64.95
10 %
Comprimés effervescents: Acidum Alendronicum 70 mg
Labatec Pharma SA
B / SL
FB
G
Ibandronic Acid (M05BA06) 16 products
WHO-DDD
L
IP
CI
Bonviva i.v.
syringe(s)
49.01
69.40
20 %
Injection solution: Acidum Ibandronicum 3mg / 3ml
Atnahs Pharma
Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Bonviva 150 mg
‐
I
Tablet(s)
17.06
35.00
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Atnahs Pharma
Switzerland AG
B / SL / SO
FB
G
L
IP
CI
Bonviva 150 mg
‐
I
3 Tablet(s)
46.57
67.25
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Atnahs Pharma
Switzerland AG
B / SL / SO
FB
G
L
IP
Ibandronat Sandoz i.v.
syringe(s)
44.11
64.35
10 %
Injection solution: Acidum Ibandronicum 3mg / 3ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
Ibandronat Spirig HC i.v. 3
mg/3 ml
Fertigspritze(n)
44.11
64.35
10 %
Injection solution: Acidum Ibandronicum 3mg / 3ml
Spirig HealthCare AG
● 
B / SL / SG
FB
G
L
IP
Ibandronat Zentiva Osteo
44.11
64.35
10 %
Injection solution: Acidum Ibandronicum 3mg / 3ml
Helvepharm AG
B / SL / SG
FB
G
L
IP
Ibandronat-Mepha Osteo
i.v. 3 mg/ 3 ml
Fertigspritze(n)
42.35
62.55
10 %
Injection solution in prefilled syringe: Acidum Ibandronicum 3mg / 3ml
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ibandronat Sandoz 150
Tablet(s)
14.43
32.30
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Ibandronat Sandoz 150
3 Tablet(s)
41.91
62.50
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
CM
Ibandronat Spirig HC 150 mg
Monatstabletten
14.43
32.30
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
CM
Ibandronat Spirig HC 150 mg
Monatstabletten
3
41.91
62.50
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Spirig HealthCare AG
● 
B / SL / SG
FB
G
L
IP
CI
Ibandronat-Mepha 150 mg
Monatstabletten
14.43
32.30
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Ibandronat-Mepha 150 mg
Monatstabletten
3
41.91
62.50
10 %
Coated tablets: Acidum Ibandronicum 150 mg
Mepha Pharma AG
● 
B / SL / SG
FB
G
L
IP
CI
Bondronat 6 mg/6 ml
Durchstechflasche(n)
178.71
210.75
10 %
Concentrate for infusion: Acidum Ibandronicum 6mg / 6ml
Atnahs Pharma
Switzerland AG
B / SL
FB
G
Bonames Filmtabletten
Tablet(s)
PR
PR
k.A.
Recordati AG
B
FB
G
Bonames Filmtabletten
3 Tablet(s)
PR
PR
k.A.
Recordati AG
B
FB
G
Risedronic Acid (M05BA07) 5 products
WHO-DDD
DrugBank.ca
IP
CI
Actonel 35 mg
4
15.44
33.20
10 %
Gastric juice resistant tablets: Natrii Risedronas 35 mg
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Actonel 35 mg
12
43.53
63.75
10 %
Gastric juice resistant tablets: Natrii Risedronas 35 mg
Future Health Pharma
GmbH
B / SL
FB
G
L
IP
CI
Actonel 35 mg
Wochentabletten
4 Tablet(s)
15.44
33.20
10 %
Coated tablets: Natrii Risedronas 35 mg
Future Health Pharma
GmbH
B / SL
FB
G
L
IP
CI
Actonel 35 mg
Wochentabletten
12 Tablet(s)
43.53
63.75
10 %
Coated tablets: Natrii Risedronas 35 mg
Future Health Pharma
GmbH
B / SL
FB
G
IP
CI
Actonel 30 mg
28 Tablet(s)
241.96
294.15
k.A.
Coated tablets: Natrii Risedronas 30 mg
Future Health Pharma
GmbH
B
FB
G
Zoledronic Acid (M05BA08) 14 products
WHO-DDD
Zoledronat Onco Labatec, 4
mg/100 ml
100 ml
PR
PR
k.A.
Infusion solution: Acidum Zoledronicum 4mg / 100ml
Labatec Pharma SA
B
FB
G
L
IP
Aclasta
Durchstechflasche(n) à 100 ml
219.40
254.45
10 %
Infusion solution: Acidum Zoledronicum 5mg / 100ml
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
IP
CI
Zometa 4 mg/5 ml
Durchstechflasche(n)
165.83
193.10
20 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
Zoledronat OSTEO Labatec
186.49
220.65
10 %
Infusion solution: Acidum Zoledronicum 5mg / 100ml
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CM
Zoledronat Osteo Sandoz 5
mg/100 ml
Durchstechflasche(n)
186.49
220.65
10 %
Infusion solution: Acidum Zoledronicum 5mg / 100ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
Zoledronat Osteo Spirig HC 5
mg/100 ml
186.49
220.65
10 %
Infusion solution: Acidum Zoledronicum 5mg / 100ml
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
Zoledronsäure Onco Sandoz 4 mg / 100 ml
100 ml
108.31
134.10
10 %
Infusion solution: Acidum Zoledronicum 4mg / 100ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Zoledronat Accord onco 4
mg/5 ml
105.85
131.55
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Accord Healthcare AG
B / SL / SG
FB
G
IP
Zoledronat Fresenius Onco 4
mg/5 ml
Durchstechflasche(n)
98.47
124.00
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
IP
Zoledronat Onco Labatec 4
mg/5 ml
Durchstechflasche(n)
108.31
134.10
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Labatec Pharma SA
B / SL / SG
FB
G
IP
Zoledronat-Teva onco 4 mg/ 5 ml
108.31
134.10
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Teva Pharma AG
B / SL / SG
FB
G
IP
CM
Zoledronsäure Onco Sandoz 4
mg/5 ml
Durchstechflasche(n)
108.31
134.10
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
Eotriz 4 mg/5 ml
PR
PR
k.A.
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
SciClone
Pharmaceuticals
Switzerland GmbH
B
FB
G
IP
Zoledronat-Acino Osteo 5mg
Durchstechflasche(n)
PR
PR
k.A.
Infusion solution: Acidum Zoledronicum 5mg / 100ml
Acino Pharma AG
B
FB
G
Alendronic Acid and Colecalciferol (M05BB03) 4 products
WHO-DDD
DrugBank.ca
L
IP
CI
Fosavance 70/2800
12 Tablet(s)
35.94
55.50
10 %
Weekly tablets: 2 Active Agents
Organon GmbH
B / SL / SO
FB
G
L
IP
CI
Fosavance 70/5600
12 Tablet(s)
35.94
55.50
10 %
Weekly tablets: 2 Active Agents
Organon GmbH
B / SL / SO
FB
G
IP
CI
Fosavance 70/2800
4 Tablet(s)
12.49
30.00
k.A.
Weekly tablets: 2 Active Agents
Organon GmbH
B
FB
G
IP
CI
Fosavance 70/5600
4 Tablet(s)
12.49
30.00
k.A.
Weekly tablets: 2 Active Agents
Organon GmbH
B
FB
G
Dibotermin Alfa (M05BC01) 2 products
WHO-DDD
DrugBank.ca
SIP
IP
InductOs 1.5 mg/ml,
poudre 12 mg
Set(s)
PR
PR
k.A.
solvant et matrice pour matrice pour implantation: Diboterminum Alfa 12 mg
Medtronic BioPharma
Sàrl
B
FB
G
SIP
IP
InductOs 1.5 mg/ml,
poudre 4 mg
PR
PR
k.A.
solvant et matrice pour matrice pour implantation: Diboterminum Alfa 4 mg
Medtronic BioPharma
Sàrl
B
FB
G
Aluminium Chlorohydrate (M05BX02) 1 products
WHO-DDD
L
IP
CI
Phosphonorm
100 Capsule(s)
31.97
51.20
10 %
Capsules: Aluminii Chloridum/hydroxidum Hydricum (9:8:19:23) 300 mg
Salmon Pharma GmbH
B / SL
FB
G
Denosumab (M05BX04) 8 products
WHO-DDD
DrugBank.ca
L
IP
CI
XGEVA 120 mg/1 ml
379.81
429.50
10 %
Injection solution in prefilled syringe: Denosumabum 120 mg
Amgen Switzerland AG
A / SL
FB
G
Wyost 120 mg/ 1.7 ml
PR
PR
k.A.
Injection solution: Denosumabum 120 mg
Sandoz
Pharmaceuticals AG
A
FB
G
IP
Xbryk 120 mg/1.7 ml
PR
PR
k.A.
Injection solution: Denosumabum 120mg / 1.7ml
Samsung Bioepis CH
GmbH
A
FB
G
Jubbonti 60 mg/ml
PR
PR
k.A.
Injection solution in prefilled syringe: Denosumabum 60 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Obodence
PR
PR
k.A.
Injection solution in prefilled syringe: Denosumabum 60 mg/ml
Samsung Bioepis CH
GmbH
B
FB
G
L
IP
XGEVA 120 mg
Durchstechflasche(n)
379.81
429.50
10 %
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Prolia
syringe(s)
249.17
287.40
10 %
Injektionslösung in Fertigspritze mit Nadelschutz: Denosumabum 60 mg/ml
Amgen Switzerland AG
B / SL
FB
G
IP
XGEVA 120 mg
4 Durchstechflasche(n)
PR
PR
k.A.
Injection solution: Denosumabum 120mg / 1.7ml
Amgen Switzerland AG
A
FB
G
Burosumab (M05BX05) 3 products
WHO-DDD
IP
Crysvita 10 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 10 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 20 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 20 mg/ml
Kyowa Kirin Sàrl
B
FB
G
IP
Crysvita 30 mg/1 ml
PR
PR
k.A.
Injection solution: Burosumabum 30 mg/ml
Kyowa Kirin Sàrl
B
FB
G
Romosozumab (M05BX06) 1 products
WHO-DDD
L
IP
CI
Evenity 105 mg/1.17 ml
2
439.49
494.40
10 %
Injection solution in prefilled syringe: Romosozumabum 105mg / 1.17ml
UCB-Pharma SA
B / SL
FB
G
Vosoritide (M05BX07) 3 products
WHO-DDD
Voxzogo 0.4 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
Voxzogo 0.56 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum
DRAC AG
A
FB
G
Voxzogo 1.2 mg
10
PR
PR
k.A.
Lyophilisate and solvent: Vosoritidum 1.2 mg
DRAC AG
A
FB
G
Sonstige die Knochenmineralisation beeinflussende Pharmaka (Diverse) (M05BX99) 1 products
WHO-DDD
DrugBank.ca
CI
A
Weleda Aufbaukalk 1+2
PR
PR
k.A.
Pulver zum Einnehmen: 2 Active Agents
Pulver zum Einnehmen: 2 Active Agents
Pulver zum Einnehmen: 3 Active Agents
Weleda AG
D
FB
G
(M05BZ) 1 products
WHO-DDD
CI
H
Dr. Reckeweg R 34
Calcossin
50 ml
PR
PR
k.A.
Drops: 5 Active Agents
Laboratoire Jacques
Reboh et fils SA
D
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home